Isa-Rd for Frail and/or Much Older Patients With Newly Diagnosed Multiple Myeloma
Isa-Rd for Frail and/or Much Older Patients With Newly Diagnosed Multiple Myeloma
Recruiting · NCT05145400 · Registry updated 2026-06-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Isa-Rd for Frail and/or Much Older Patients With Newly Diagnosed Multiple Myeloma | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cancer, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Recruiting | Phase 2 | 2026-06-02 | NCT05145400 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Genzyme, a Sanofi Company | 22 |
| UNC Lineberger Comprehensive Cancer Center | 125 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Duke Comprehensive Cancer Center | Durham | United States | 1 |
| Levine Cancer Institute | Charlotte | United States | 110 |
| Novant Health New Hanover Regional Medical Center | Wilmington | United States | 30 |
| The Ohio State University Comprehensive Cancer Center | Columbus | United States | 29 |
| University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center | Chapel Hill | United States | 2 |